The latest news from AAD 2025 focused on psoriasis including abstracts, features, and helpful conference information.
Psoriasis affects 7.5M+ U.S. adults, with new targeted treatments, diet links, and patient-centered care improving outcomes. Advances offer hope for better management.
Review highlights emerging psoriasis therapies, including IL-21, Snora73, gut microbiome, and natural treatments, offering new patient-centered options.
The 2025 AAD Meeting features key psoriasis sessions on therapies, JAK inhibitors, obesity links, patient care gaps, and cutting-edge treatment advances.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
